We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Research ArticleFree Access

Predictors of poor precautionary practices towards COVID-19 among cancer patients

    Abdul R Jazieh

    *Author for correspondence:

    E-mail Address: Jaziehoncology@gmail.com

    Cincinnati Cancer Advisors, Cincinnati, OH, USA

    ,
    Assia A Bensalem

    Medical Oncology Department, Établissement Hospitalier DIDOUCHE Mourad, Faculté de medicine, Université de Constantine 3, Constantine, Algeria

    ,
    Adda Bounedjar

    Université Blida 1 Laboratoire de cancérologie, Faculté de Médecine, BP 270, Route de soumaa, Blida, Algeria

    ,
    Zineb Benbrahim

    Medical Oncology, Faculty of Medicine & Pharmacy of Fez, University Sidi Mohamed Ben Abdellah, Fez, Morocco

    ,
    Mohamed O Alorabi

    Ain Shams Faculty of Medicine, Clinical Oncology Department, Cairo, Egypt

    ,
    Atlal M Abusanad

    Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

    ,
    Emad M Tashkandi

    College of Medicine, Umm Alqura University, Oncology Center, King Abdullah Medical City, Makkah, Saudi Arabia

    ,
    Muath AMA Alnassar

    Kuwait Cancer Control Cancer, Kuwait City, Kuwait

    ,
    Abdul RAD El Kinge

    Hematology Oncology Service, NMC Royal Hospital Sharjah, Sharjah University, Sharjah, UAE

    ,
    Sana Al-Sukhun

    Hematology/Medical Oncology, Al-Hyatt Oncology Practice, Amman, Jordan

    ,
    Abdullah Alsharm

    Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia

    ,
    Hassan Errihani

    National Institute of Oncology, Mohammed V University, Rabat, Morocco

    ,
    Nafisa A Abdelhafiez

    Department of Oncology, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia

    ,
    Mohammad Alkaiyat

    Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

    &
    Hoda Jradi

    College of Public Health & Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

    Published Online:https://doi.org/10.2217/fon-2021-0193

    Objective: Our study goal was to evaluate the behavioral response and practices of cancer patients to the coronavirus disease 2019 (COVID-19) pandemic in the Middle East and north Africa. Methods: A cross-sectional study was conducted using a validated anonymous 45-question survey administered via SurveyMonkey® to cancer patients in 13 centers in Algeria, Egypt, Jordan, Kuwait, Morocco and Saudi Arabia. Results: During the study period (from 21 April to 30 May 2020), 3642 patients participated in the study. The majority of patients (84.81%) were worried about contracting the infection. The reported strict adherence to precautions included avoiding the following actions: hand-shaking (77.40%), hugging and kissing (82.89%), social gathering (90.09%), meeting friends (84.68%) and visiting markets (75.65%). In a multivariate analysis, patients with poor precautionary practices were about twice as likely to cancel their medical appointment or a treatment session. Conclusion: Improving cancer patients’ knowledge of and adherence to precautionary measures is needed not just to reduce the risk of acquiring infection but also to minimize the interruption of their medical care.

    Lay abstract

    COVID-19 poses a higher risk for patients with cancer than other patients; therefore, it is prudent that they adhere to precautionary measures to protect themselves from the infection. We conducted a study to evaluate the behaviors and practices of these patients in response to the COVID-19 pandemic in the Middle, East and North Africa. We developed a survey of 45 questions that was distributed in 13 centers in Algeria, Egypt, Jordan, Kuwait, Morocco and Saudi Arabia between 21 April and 30 May 2020. About 85% of the 3642 patients who participated in the study were worried about contracting the infection. A substantial percentage of them (10–30%) were not adhering to various precautions and social distancing rules. On the other hand, 16% of them canceled medical appointments and 12% canceled treatment sessions. Our study showed the need for better adherence of patients with cancer to the infection precautions and most importantly, the need to have a better compliance with their treatment plans, such as keeping their scheduled appointments, to avoid harms from treatment delays.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Johns Hopkins Coronavirus Resource Center. COVID-19 map. https://coronavirus.jhu.edu/map.html
    • 2. Richards M, Anderson M, Carter P, Ebert B, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer doi:10.1038/s43018-020-0074-y (2020) (Epub ahead of print).
    • 3. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzoo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19. Ann. Intern. Med. 172(11), 756–758 (2020). •• Describes various challenges of delivering cancer care during the pandemic and associated risks.
    • 4. Kuderer N, Choueiri T, Shah D et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395(10241), 1907–1918 (2020). • One of the early global registries of patients with cancer and COVID-19; showed increased risk of mortality among this patient population.
    • 5. Nagar H, Formenti SC. Cancer and COVID-19 – potentially deleterious effects of delaying radiotherapy. Nat. Rev. Clin. Oncol. 17(6), 332–334 (2020).
    • 6. Sud A, Jones ME, Broggio J et al. Collateral damage: the impact on cancer outcomes of the COVID-19 pandemic. Ann. Oncol. 31(8), 1065–1074 (2020).
    • 7. Razavi AS, Hamblin MR, Rezaei N. COVID-19 in patients with cancer: risks and precautions. Am. J. Emerg. Med. doi:10.1016/j.ajem.2021.01.067 (2021) (Epub ahead of print).
    • 8. Ioannidis JPA. Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures. Eur. J. Clin. Invest. 50(4), e13222 (2020). •• Gives various examples of exaggerated news and their potential harms.
    • 9. Al-Hanawi MK, Angawi K, Alshareef N et al. Knowledge, attitude and practice toward COVID-19 among the public in the Kingdom of Saudi Arabia: a cross-sectional study. Front. Public Health 8, 217 (2020).
    • 10. Abdelhafiz AS, Mohammed Z, Ibrahim ME et al. Knowledge, perceptions, and attitude of Egyptians towards the novel coronavirus disease (COVID-19). J. Community Health 45(5), 881–890 (2020).
    • 11. Brunetti O, Deakhshani A, Baradaran B, Galvano A, Russo A, Silvestris N. COVID-19 infection in cancer patients: how can oncologists deal with these patients? Front. Oncol. 10, 734 (2020).
    • 12. Sato Y, Fujiwara Y, Fukuda N et al. Changes in treatment behavior during the COVID-19 pandemic among patients at a cancer hospital. 39(2), 130–131 (2021).
    • 13. Pradhan D, Biswasroy P, Kumar PN, Ghosh G, Rath G. A review of current interventions for COVID-19 prevention. Arch. Med. Res. 51(5), 363–374 (2020).
    • 14. Zhong BL, Luo W, Li HM et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int. J. Biol. Sci. 16(10), 1745–1752 (2020).
    • 15. Lee M, You M. Psychological and behavioral responses in South Korea during the early stages of coronavirus disease 2019 (COVID-19). Int. J. Environ. Res. Public Health 17(9), 2977 (2020).
    • 16. Wolf MS, Serper M, Opsasnick L et al. Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the US outbreak. Ann. Intern. Med. 173(2), 100–109 (2020).
    • 17. Musche V, Bauerle A, Steinbach J et al. COVID-19-related fear and health-related safety behavior in oncological patients. Front. Psychol. 11, 1984 (2020).
    • 18. Casanova M, Bagliacca EP, Silva M et al. How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: is there room for other fears? Pediatr. Blood Cancer 67(7), e28318 (2020).
    • 19. Sari DK, Amelia R, Dharmajaya R, Sari LM, Fitri NK. Positive correlation between general public knowledge and attitudes regarding COVID-19 outbreak 1 month after first cases reported in Indonesia. J. Community Health 46(1), 182–189 (2020).
    • 20. Bruine de Bruin W, Bennett D. Relationships between initial COVID-19 risk perceptions and protective health behaviors: a national survey. Am. J. Prev. Med. 59(2), 157–167 (2020).
    • 21. Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat. Rev. Clin. Oncol. 17(5), 268–270 (2020). • Shows the prioritization approach in the patients with cancer.
    • 22. American Society of Clinical Oncology. ASCO special report: a guide to cancer care delivery during the COVID-19 pandemic. https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf?fbclid=IwAR1-_xQbixie3zcRiqejzXsXYXviherzkfjKnLn8ZJGhNrHZG93XRVGUbzg
    • 23. Curigliano G, Banerjee S, Cervantes A et al. Managing cancer patients during the COVID-19 pandemic: an ESMO interdisciplinary expert consensus. Ann. Oncol. 31(10), 1320–1335 (2020).
    • 24. Gregucci F, Caliandro M, Surgo A et al. Cancer patients in COVID-19 era: swimming against the tide. Radiother. Oncol. 149, 109–110 (2020). •• Describes various challenges faced by cancer patients during the pandemic.
    • 25. Li W, Liao J, Li Q et al. Public health education for parents during the outbreak of COVID-19: a rapid review. Ann. Transl. Med. 8(10), 628–628 (2020). • Showed the public’s need for proper education and the importance of getting the information from credible sources.
    • 26. Geldsetzer P. Knowledge and perceptions of COVID-19 among the general public in the United States and the United Kingdom: a cross-sectional online survey. Ann. Intern. Med. 173(2), 157–160 (2020).
    • 27. Vanni G, Materazzo M, Pellicciaro M et al. Breast cancer and COVID-19: the effect of fear on patients’ decision-making process. In Vivo 34(Suppl. 3), 1651–1659 (2020).
    • 28. Armellini E, Repici A, Alvisi C et al. Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in Italy. Dig. Liver Dis. 52(7), 695–699 (2020).
    • 29. Tashkandi E, Baabdullah M, Zeeneldin A et al. Optimizing the communication with cancer patients during the COVID-19 pandemic: patient perspectives. Patient Prefer. Adherence 14, 1205–1212 (2020).
    • 30. Ghosh J, Ganguly S, Mondal D et al. Perspective of oncology patients during COVID-19 pandemic: a prospective observational study from India. JCO Glob. Oncol. 6, 844–851 (2020).
    • 31. London JW, Fazio-Eynullayeva E, Palchuk MB, Sankey P, McNair C. Effects of the COVID-19 pandemic on cancer-related patient encounters. JCO Clin. Cancer Inform. 4, 657–665 (2020). •• Study showing the impact of the pandemic on reducing cancer patients’ encounters and discussing the potential harm of that.
    • 32. Erdem D, Karaman I. Awareness and perceptions related to COVID-19 among cancer patients: a survey in oncology department. Eur. J. Cancer Care (Engl.) 29(6), e13309 (2020).
    • 33. Sah GS, Shrestha G, Dhakal A, Mulmi R, Sapkota A, Poudel S. Knowledge, attitudes, and practices of cancer patients towards COVID-19: a cross-sectional study in central Nepal. Cancer Manag. Res. 12, 10173–10180 (2020).